XML 36 R30.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders' Equity
9 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Stockholders' Equity

Note 20. Stockholders’ equity

Common stock and treasury stock

Activity in common stock and treasury stock share is as follows:

 

 

Common Stock

 

 

Treasury Stock

 

 

Treasury stock held for deferred compensation

 

Balances as of April 1, 2023

 

 

72,960

 

 

 

(13,022

)

 

 

(67

)

Purchase of treasury stock

 

 

 

 

 

 

 

 

 

Sales of treasury stock

 

 

 

 

 

268

 

 

 

 

Common shares issued for benefit plans

 

 

 

 

 

 

 

 

 

Purchases of stock by deferred compensation

 

 

 

 

 

 

 

 

 

Distribution of stock from deferred compensation

 

 

 

 

 

 

 

 

11

 

Balances as of June 30, 2023

 

 

72,960

 

 

 

(12,754

)

 

 

(56

)

 

 

 

 

 

 

 

 

 

 

Balances as of April 1, 2024

 

 

72,960

 

 

 

(12,185

)

 

 

(53

)

Purchase of treasury stock

 

 

 

 

 

(1,692

)

 

 

 

Sales of treasury stock

 

 

 

 

 

606

 

 

 

 

Common shares issued for benefit plans

 

 

 

 

 

21

 

 

 

 

Purchases of stock by deferred compensation

 

 

 

 

 

 

 

 

 

Distribution of stock from deferred compensation

 

 

 

 

 

 

 

 

1

 

Balances as of June 30, 2024

 

 

72,960

 

 

 

(13,250

)

 

 

(52

)

 

 

 

Common Stock

 

 

Treasury Stock

 

 

Treasury stock held for deferred compensation

 

Balances as of September 30, 2022

 

 

72,960

 

 

 

(13,207

)

 

 

(139

)

Purchase of treasury stock

 

 

 

 

 

(274

)

 

 

 

Sales of treasury stock

 

 

 

 

 

538

 

 

 

 

Common shares issued for benefit plans

 

 

 

 

 

189

 

 

 

 

Purchases of stock by deferred compensation

 

 

 

 

 

 

 

 

(1

)

Distribution of stock from deferred compensation

 

 

 

 

 

 

 

 

84

 

Balances as of June 30, 2023

 

 

72,960

 

 

 

(12,754

)

 

 

(56

)

 

 

 

 

 

 

 

 

 

Balances as of September 30, 2023

 

 

72,960

 

 

 

(13,070

)

 

 

(55

)

Purchase of treasury stock

 

 

 

 

 

(1,692

)

 

 

 

Sales of treasury stock

 

 

 

 

 

1,332

 

 

 

 

Common shares issued for benefit plans

 

 

 

 

 

180

 

 

 

 

Purchases of stock by deferred compensation

 

 

 

 

 

 

 

 

(1

)

Distribution of stock from deferred compensation

 

 

 

 

 

 

 

 

4

 

Balances as of June 30, 2024

 

 

72,960

 

 

 

(13,250

)

 

 

(52

)

Stock repurchase program

In January 2022, the Woodward board of directors (the "Board") authorized a program for the repurchase of up to $800,000 of Woodward’s outstanding shares of common stock on the open market or in privately negotiated transactions over a two-year period ending in January 2024 (the “2022 Authorization”). During the first nine months of fiscal year 2023, Woodward repurchased 274 shares of its common stock for $26,369 under the 2022 Authorization.

In January 2024, the Board terminated the 2022 Authorization, which was nearing expiration, and concurrently authorized a new program for the repurchase of up to $600,000 of Woodward’s outstanding shares of common stock on the open market or in privately negotiated transactions over a three-year period ending in January 2027 (the “2024 Authorization”). During the first nine months of fiscal year 2024, Woodward repurchased 1,692 shares of its common stock for $304,811, with all such repurchases made under the 2024 Authorization.

Stock-based compensation

Provisions governing outstanding stock option awards, restricted stock units ("RSUs"), and performance restricted stock units ("PSUs") are included in the 2017 Omnibus Incentive Plan, as amended from time to time (the “2017 Plan”) and, with respect to outstanding stock options awarded in or prior to 2016, the 2006 Omnibus Incentive Plan (the “2006 Plan”).

The 2017 Plan was first approved by Woodward’s stockholders in January 2017 and is the successor plan to the 2006 Plan. The Board has delegated authority to administer the 2017 Plan to the Compensation Committee of the Board, including, but not limited to, the power to determine the recipients of awards and the terms of those awards. On January 25, 2023, Woodward’s stockholders approved an additional 500 shares of Woodward’s common stock to be made available for future grants. Under the 2017 Plan, there were approximately 2,158 shares of Woodward’s common stock available for future grants as of June 30, 2024 and 2,689 shares as of September 30, 2023.

Stock options

Stock option awards are granted with an exercise price equal to the market price of Woodward’s stock at the date the grants are awarded, a ten-year term, and generally have a four-year vesting schedule at a rate of 25% per year.

The fair value of options granted is estimated as of the grant date using the Black-Scholes-Merton option-valuation model. Woodward calculates the expected term, which represents the average period of time that stock options granted are expected to be outstanding, based upon historical experience of plan participants. Expected volatility is based on historical volatility using daily stock price observations. The estimated dividend yield is based upon Woodward’s historical dividend practice and the market value of its common stock. The risk-free rate is based on the U.S. treasury yield curve, for periods within the contractual life of the stock option, at the time of grant.

The following is a summary of the activity for stock option awards:

 

 

Three Months Ended June 30, 2024

 

 

Nine Months Ended June 30, 2024

 

 

 

Number of options

 

 

Weighted-Average Exercise Price per Share

 

 

Number of options

 

 

Weighted-Average Exercise Price per Share

 

Beginning balance

 

 

4,213

 

 

$

83.54

 

 

 

4,842

 

 

$

80.48

 

Granted

 

 

 

 

 

 

 

 

87

 

 

 

137.36

 

Exercised

 

 

(603

)

 

 

70.05

 

 

 

(1,313

)

 

 

69.58

 

Forfeited

 

 

(6

)

 

 

101.40

 

 

 

(12

)

 

 

96.82

 

Ending balance

 

 

3,604

 

 

$

85.77

 

 

 

3,604

 

 

$

85.77

 

Changes in non-vested stock options were as follows:

 

 

Three Months Ended June 30, 2024

 

 

Nine Months Ended June 30, 2024

 

 

 

Number of options

 

 

Weighted-Average Grant Date Fair Value per Share

 

 

Number of options

 

 

Weighted-Average Grant Date Fair Value Per Share

 

Beginning balance

 

 

926

 

 

$

37.40

 

 

 

1,393

 

 

$

33.96

 

Granted

 

 

 

 

 

 

 

 

87

 

 

 

58.34

 

Vested

 

 

(20

)

 

 

38.87

 

 

 

(569

)

 

 

32.25

 

Forfeited

 

 

(5

)

 

 

40.25

 

 

 

(10

)

 

 

37.76

 

Ending balance

 

 

901

 

 

$

37.35

 

 

 

901

 

 

$

37.35

 

Information about stock options that have vested, or are expected to vest, and are exercisable at June 30, 2024 was as follows:

 

 

Number of options

 

 

Weighted-Average Exercise Price

 

 

Weighted-Average Remaining Life in Years

 

 

Aggregate Intrinsic Value

 

Options outstanding

 

 

3,604

 

 

$

85.77

 

 

 

5.5

 

 

$

319,417

 

Options vested and exercisable

 

 

2,703

 

 

 

81.80

 

 

 

4.7

 

 

 

250,231

 

Options vested and expected to vest

 

 

3,575

 

 

 

85.61

 

 

 

5.5

 

 

 

317,387

 

Restricted stock units

The Company generally grants RSUs to eligible employees under its form RSU agreement for employees (the “Standard Form RSU Agreement”). RSUs granted under the Standard Form RSU Agreement prior to November 14, 2023, generally have a four-year vesting schedule at a rate of 25% per year, and RSUs granted after November 14, 2023 have a three-year vesting schedule at a rate of 33.3% per year, in each case generally subject to continued employment.

The Company has also granted RSUs to certain employees under its form attraction and retention RSU agreement (the “Form Attraction and Retention RSU Agreement”), which has from time to time been used for new hires and specific

retention purposes. RSUs granted under the Form Attraction and Retention Agreement are generally scheduled to fully vest on the third or fourth anniversary of the respective grant dates, and in each case, subject to continued employment.

A summary of the activity for RSUs:

 

 

Three Months Ended June 30, 2024

 

 

Nine Months Ended June 30, 2024

 

 

 

Number of units

 

 

Weighted-Average Grant Date Fair Value

 

 

Number of units

 

 

Weighted-Average Grant Date Fair Value

 

Beginning balance

 

 

319

 

 

$

116.90

 

 

 

177

 

 

$

93.46

 

Granted

 

 

5

 

 

 

177.26

 

 

 

172

 

 

 

138.53

 

Released

 

 

(4

)

 

 

99.36

 

 

 

(28

)

 

 

88.63

 

Forfeited

 

 

(6

)

 

 

115.26

 

 

 

(7

)

 

 

114.19

 

Ending balance

 

 

314

 

 

$

118.17

 

 

 

314

 

 

$

118.17

 

Performance restricted stock units

In November 2023, the Company granted PSUs to certain employees under its form PSU agreement that generally will vest subject to a market condition and a service condition through the performance period. The market condition associated with the awards is based on the Company's relative total shareholder return ("TSR") compared to the TSR generated by the other companies that comprise the S&P 400 Midcap Index over a three-year performance period. Performance at target will result in vesting and issuance of the number of PSUs granted, equal to 100% payout. Performance below or above target can result in an issuance of between 0% - 150% of the target number of PSUs granted. Expense is recognized based on the weighted average grant date fair value on a straight line basis over the service period, irrespective as to whether the market condition is achieved.

The fair value of the PSUs for the November 2023 grant was determined based upon a Monte Carlo valuation method. The assumptions used in the Monte Carlo method to value the PSUs granted, which includes the grant date fair value outcome from the Monte Carlo method, were as follows:

 

 

June 30, 2024

 

Expected volatility

 

 

30.2

%

Risk free interest rate

 

 

4.5

%

Expected life

 

3 years

 

Grant date fair value

 

$

146.47

 

The PSUs granted receive dividend equivalent units; therefore, no discount was applied for Woodward’s dividends.

A summary of the activity for PSUs:

 

 

Three Months Ended June 30, 2024

 

 

Nine Months Ended June 30, 2024

 

 

 

Number of units

 

 

Weighted-Average Grant Date Fair Value

 

 

Number of units

 

 

Weighted-Average Grant Date Fair Value

 

Beginning balance

 

 

66

 

 

$

146.47

 

 

 

 

 

$

 

Granted

 

 

 

 

 

 

 

 

66

 

 

 

146.47

 

Forfeited

 

 

(4

)

 

 

146.47

 

 

 

(4

)

 

 

146.47

 

Ending balance

 

 

62

 

 

$

146.47

 

 

 

62

 

 

$

146.47

 

Stock-based compensation expense

Woodward recognizes stock-based compensation expense on a straight-line basis over the requisite service period. Pursuant to form stock option agreements, form RSU agreements, and form PSU agreements used by the Company, with terms approved by the administrator of the applicable plan, the requisite service period can be less than the vesting period defined in the applicable award agreement based on grantee’s retirement eligibility. As such, the recognition of stock-based compensation expense associated with some stock option grants, RSU grants, and PSU grants can be accelerated to a period of less than the vesting period, including immediate recognition of stock-based compensation expense on the date of grant.

In connection with an executive separation and release agreement entered into by the Company during the second quarter of fiscal year 2024, Woodward recognized an additional $1,682 of stock compensation expense, before tax.

At June 30, 2024, there was approximately $31,716 of total unrecognized compensation expense related to non-vested stock-based compensation arrangements, including stock options, RSUs, and PSUs. The pre-vesting forfeiture rates for purposes of determining stock-based compensation expense recognized were estimated to be 0.0% for members of the Board and 7.3% for all others. The remaining unrecognized compensation cost is expected to be recognized over a weighted-average period of approximately 1.9 years.